(Q54397130)

English

CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

author name string

Shaoqiong Duan

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Guoyu Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Qunying Han

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Zhu Li

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Zhengwen Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Jinghong Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Yi Lv

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Na Li

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Yawen Wang

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Man Li

10

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Sai Lou

11

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Mingbo Yang

12

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Qianqian Zhu

13

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Fanfan Xing

14

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

publication date

15 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Molecular Biology Reports

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

38

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

5125-5132

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

CTLA-4 can function as a negative regulator of T cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

+49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

A molecular perspective of CTLA-4 function

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Association ofCTLA4Polymorphisms with Sustained Response to Interferon and Ribavirin Therapy for Chronic Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Haplotype tagging for the identification of common disease genes

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0660-7

21 January 2018

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21161390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11033-010-0660-7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

release_j4lmeswmdreepgegalbji3aigi

1 reference

https://api.fatcat.wiki/v0/release/j4lmeswmdreepgegalbji3aigi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21161390

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54397130&oldid=2212452539"